Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessTEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
The distant metastasis is the primary cause of cancer morbidity and mortality for bladder cancer (BLCA) paitents. All the recommended therapy for it largely depends on how far the cancer has invaded. It has be...
-
Article
Targeted drug development in melanoma and nonsmall cell lung cancer: BRAF, MEK, and ALK inhibitors
In the past few decades, many advances have been witnessed in the development of personalized molecular therapies, especially in the areas of melanoma and nonsmall cell lung cancer (NSCLC) among all other medi...